Logo

23andMe

In Brief This Week: NIH, CMT Research Foundation, Taiba Healthcare, 23andMe, Adverum

News items for the week of July 29, 2024.

23andMe, Advocacy Groups Launch Lung Cancer Genetics Study

23andMe and its collaborators seek 10,000 adult participants with any type of lung cancer to take part in at-home testing to help uncover the genetics of lung cancer.

23andMe to Fund Sickle Cell Carrier Awareness Program With DNA Testing, Reporting

Working with nonprofit Sickle Cell 101, 23andMe will provide testing and status reports to African Americans, building on an earlier Georgia collaboration.

FDA Clears 23andMe BRCA1/2 Consumer Health Risk Report for 41 Additional Variants

The 510(k) clearance will allow 23andMe to offer breast, ovarian, prostate, and pancreatic cancer risk assessments for a broader range of populations.

American Heart Association Project Aims to Fill Guidelines Gap for Lp(a) Screening, Care Management
Premium

Novartis Pharmaceuticals has backed two cardiovascular care projects studying lipoprotein(a) in the past month: one with the American Heart Association and another with 23andMe.